ArticleEuropean heart journal2015
Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors.
Article in European heart journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores.Journal of the American Heart Association · 2018Trial
- Acute Decompensated Heart Failure Complicated by Ischemic Stroke and Its Association With Hemoglobin Levels.Circulation reports · 2026Article
- Performance of Bleeding Risk Scores for Major Bleeding in Anticoagulated Patients with Pulmonary Embolism: Insights from the CURES Registry-2.Thrombosis and haemostasis · 2026Article
- The Value of Clinical Prediction Models in General Practice: A Qualitative Study Exploring the Perspectives of People With Lived Experience of Depression and General Practitioners.Health expectations : an international journal of public participation in health care and health policy · 2024Article
- Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke.Cardiovascular drugs and therapy · 2024Article
- Impact of longitudinal data-completeness of electronic health record data on risk score misclassification.Journal of the American Medical Informatics Association : JAMIA · 2022Article
- Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation.BMC cardiovascular disorders · 2021Observational
- Observational
- A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction.Open medicine (Warsaw, Poland) · 2020Article
- Article
- Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation.Scientific reports · 2017Article
- Review
- Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?Scientific reports · 2017Article
- Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores.Scientific reports · 2016Article
- Emerging Tools for Stroke Prevention in Atrial Fibrillation.EBioMedicine · 2016Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
26351397What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.